Adjuvant therapy no significant increase disease free survival

This study is based on single agent gemcitabine following resection. No increased overall survival
https://www.jstage.jst.go.jp/article/shinshumedj/65/2/65_99/_pdf

A total of 55 patients were enrolled, majority CCA
14 intrahepatic
34 extrahepatic
others were:
3 gallbladder
4 ampulla of vater

According to this study eventual outcome of extra hepatic patients treated with adjuvant Gemcitabine was similar to that of resected patients only.

Would love to see in detail data of intrahepatic patients.

Marion